Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic Fibrosis-Reference-Cited by-同舟云学术

Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic Fibrosis

Published:2009-04 Issue:4 Volume:47 Page:1231-1233
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Goodrich Jennifer S.¹,Sutton-Shields Tameaka N.¹,Kerr Alan¹,Wedd Joel P.²,Miller Melissa B.¹³,Gilligan Peter H.¹³

Affiliation:

1. Clinical Microbiology-Immunology Laboratories, University of North Carolina Hospitals

2. University of North Carolina School of Public Health

3. Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Abstract

ABSTRACT We prospectively determined the prevalence of community-associated Staphylococcus aureus in a large cystic fibrosis (CF) center between October 2005 and October 2007. We found that 2.7% (19/707) of the CF patients who had cultures during the study period were infected with this organism, representing 14% of the total methicillin-resistant Staphylococcus aureus strains ( n = 140) recovered from the patient population during the study period.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00255-09

Reference17 articles.

1. Performance standard for antimicrobial susceptiblity testing; 16th informational supplement. 2006

2. Patient registry 2006 annual report. 2007

3. Dasenbrook, E. C., C. A. Merlo, M. Diener-West, N. Lechtzin, and M. P. Boyle. 2008. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am. J. Respir. Crit. Care Med.178:814-821.

4. Elizur, A., R. C. Orscheln, T. W. Ferkol, J. J. Atkinson, W. M. Dunne, Jr., R. S. Buller, J. R. Armstrong, E. R. Mardis, G. A. Storch, and C. L. Cannon. 2007. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest131:1718-1725.

5. Finck-Barbançon, V., G. Duportail, O. Meunier, and D. A. Colin. 1993. Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim. Biophys. Acta1182:275-282.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-to-first-isolation of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF): An underutilised metric in infection control?;Infection, Disease & Health;2023-11

2. Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial;ERJ Open Research;2022-10

3. A Middle East systematic review and meta-analysis of prevalence and antibiotic susceptibility pattern in MRSA Staphylococcus aureus isolated from patients with cystic fibrosis;Journal of Health, Population and Nutrition;2022-06-28

4. Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis;Journal of Cystic Fibrosis;2021-07

5. Bacterial Infections and the Respiratory Microbiome;Respiratory Medicine;2020